Menu Back toSession-10-Senior-Leaders-FDA-and-Industry-Town-Hall

DIA/FDA Biostatistics Industry and Regulator Forum

Session 10: Senior Leaders (FDA and Industry) Town Hall

    Session Chair(s)
      Dionne  Price, PhD

      Dionne Price, PhD

      • Acting Deputy Director, Office of Biostatistics, OTS, CDER
      • FDA, United States
      Cristiana  Mayer, PhD

      Cristiana Mayer, PhD

      • Scientific Director, Statistical Modeling and Methodology, SDS
      • Janssen Research and Development LLC, United States
    Welcome to the Town Hall! Dedicated to sharing the latest information on new guidances, this session will allow open discussion between the audience and an esteemed panel of regulatory and industry experts. Questions asked from the audience may focus on the sessions held during this forum, but can also branch out into other areas of regulatory statistics. Panelists will address questions posed by attendees live from the Town Hall as well as those submitted throughout the forum.
      Jose C. Pinheiro, PhD

      Jose C. Pinheiro, PhD

      • Head of Statistical Modeling and Methodology, SDS
      • Janssen Research & Development, LLC, United States
      Nevine  Zariffa


      Nevine Zariffa

      • Vice President and Head Biometrics & Information Sciences
      • Astrazeneca Pharmaceuticals, United States
      Ram  Tiwari, PhD


      Ram Tiwari, PhD

      • Director, Division of Biostatistics, CDRH
      • FDA, United States
      John  Scott, PhD

      John Scott, PhD

      • Acting Director, Division of Biostatistics, OBE, CBER
      • FDA, United States
      Pandurang M Kulkarni, PhD

      Pandurang M Kulkarni, PhD

      • Vice President, Global Biometrics & Advanced Analytics
      • Eli Lilly and Company, United States
      Aloka  Chakravarty, PhD

      Aloka Chakravarty, PhD

      • Acting Director, Office of Biostatistics, Office of Translational Sciences, CDER
      • FDA, United States